β1, β2, and β3 adrenoceptors and Na+/H + Exchanger Regulatory Factor 1 expression in human bronchi and their modifications in cystic fibrosis

American Journal of Respiratory Cell and Molecular Biology

Volumn 44, Issue 1, 2010, Pages 91-98

  Bossard, Florian ^a,b,c   Silantieff, Émilie ^a,b,c   Lavazais Blancou, Emmanuelle ^a,b,c   Robay, Amal ^a,b,c   Sagan, Christine ^d   Rozec, Bertrand ^a,b,d   Gauthier, Chantal ^a,b,c  

^a L INSTITUT DU THORAX   (France)

^b CNRS   (France)

^c UNIVERSITÉ DE NANTES   (France)

^d NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

adrenergic receptor; Bronchus; Cystic fibrosis; Epithelium; NHERF1

Indexed keywords

ANTIBIOTIC AGENT; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 3 ADRENERGIC RECEPTOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; SODIUM HYDROGEN EXCHANGER REGULATORY FACTOR 1; SODIUM PROTON EXCHANGE PROTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG;

ADRENERGIC ACTIVITY; ADULT; ARTICLE; BRONCHUS; BRONCHUS MUCOSA; CELL LINE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; EPITHELIUM CELL; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HISTOPATHOLOGY; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION; INFLAMMATION; LUNG; LUNG FLUID; MALE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION;

ADRENERGIC BETA-AGONISTS; ADULT; AGED; ALBUTEROL; BENZOIC ACIDS; BRONCHI; CASE-CONTROL STUDIES; CELL LINE; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DOBUTAMINE; FEMALE; FORSKOLIN; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; PHOSPHOPROTEINS; PRAZOSIN; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, ADRENERGIC, BETA-3; RNA, MESSENGER; SODIUM-HYDROGEN ANTIPORTER; THIAZOLIDINES; YOUNG ADULT;

EID: 78650659673     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2009-0372OC     Document Type: Article

References (39)

1. Bennett WD. Effect of beta-adrenergic agonists on mucociliary clearance. J Allergy Clin Immunol 2002;110 (Suppl. 6)S291-S297.
2. Carstairs JR, Nimmo AJ, Barnes PJ. Autoradiographic visualization of beta-adrenoceptor subtypes in human lung. Am Rev Respir Dis 1985; 132:541-547.
3. Mak JC, Nishikawa M, Haddad EB, Kwon OJ, Hirst SJ, Twort CH, Barnes PJ. Localisation and expression of beta-adrenoceptor subty pe mRNAs in human lung. Eur J Pharmacol 1996;302:215-221.
4. Frielle T, Collins S, Daniel KW, Caron MG, Lefkowitz RJ, Kobilka BK. Cloning of the cDNA for the human beta 1-adrenergic receptor. Proc Natl Acad Sci USA 1987;84:7920-7924.
5. Emorine LJ, Marullo S, Briend-Sutren MM, Patey G, Tate K, Delavier-Klutchko C, Strosberg AD. Molecular characterization of the human beta 3-adrenergic receptor. Science 1989;245:1118-1121.
6. Xiao RP, Ji X, Lakatta EG. Functional coupling of the beta 2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes. Mol Pharmacol 1995;47:322-329.
7. Gauthier C, Tavernier G, Charpentier F, Langin D, Le Marec H. Functional beta3-adrenoceptor in the human heart. J Clin Invest 1996;98:556-562.
8. Rozec B, Gauthier C. [Beta]3-adrenoceptors in the cardiovascular system: putative roles in human pathologies. Pharmacol Ther 2006; 111:652-673.
9. Arch JR, Ainsworth AT, Cawthorne MA, Piercy V, Sennitt MV, Thody VE, Wilson C, Wilson S. Atypical beta-adrenoceptor on brown adipocytes as target for anti-obesity drugs. Nature 1984;309:163-165.
10. Takeyama K, Tamaoki J, Chiyotani A, Sakai N, Kanemura T, Konno K. Stimulation of ciliary motility by beta 3-adrenoceptor agonist rabbit tracheal epithelium [in Japanese]. Kokyu To Junkan 1993;41: 993-997.
11. Tamaoki J, Chiyotani A, Sakai N, Konno K. Stimulation of ciliary motility mediated by atypical beta-adrenoceptor in canine bronchial epithelium. Life Sci 1993;53:1509-1515.
12. Danner I, Escande D, Gauthier C. Beta(3)-adrenoceptors control Cl(2) conductance in rabbit nasal epithelium. Eur J Pharmacol 2001;422: 203-207.
13. Krief S, Lonnqvist F, Raimbault S, Baude B, Van Spronsen A, Arner P, Strosberg AD, Ricquier D, Emorine LJ. Tissue distribution of beta 3-adrenergic receptor mRNA in man. J Clin Invest 1993;91:344-349.
14. Davis PB, Braunstein M, Jay C. Decreased adenosine 39:59-monophosphate response to isoproterenol in cystic fibrosis leukocytes. Pediatr Res 1978;12:703-707.
15. Davis PB, Kaliner M. Autonomic nervous system abnormalities in cystic fibrosis. J Chronic Dis 1983;36:269-278.
16. Frizzell RA, Rechkemmer G, Shoemaker RL. Altered regulation of airway epithelial cell chloride channels in cystic fibrosis. Science 1986; 233:558-560.
17. Gu X, Wang Z, Xu J, Maeda S, Sugita M, SagawaM, Toga H, Sakuma T. Denopamine stimulates alveolar fluid clearance via cystic fibrosis transmembrane conductance regulator in rat lungs. Respirology 2006; 11:566-571.
18. Mutlu GM, Adir Y, Jameel M, Akhmedov AT, Welch L, Dumasius V, Meng FJ, Zabner J, Koenig C, Lewis ER, et al. Interdependency of beta-adrenergic receptors and CFTR in regulation of alveolar active Na+ transport. Circ Res 2005;96:999-1005.
19. Robay A, Toumaniantz G, Leblais V, Gauthier C. Transfected beta3-but not beta2-adrenergic receptors regulate cystic fibrosis transmembrane conductance regulator activity via a new pathway involving the mitogen-activated protein kinases extracellular signal-regulated kinases. Mol Pharmacol 2005;67:648-654.
20. + exchanger regulatory factor family of PDZ proteins. Proc Natl Acad Sci USA 1998;95:8496-8501.
21. He J, Bellini M, Inuzuka H, Xu J, Xiong Y, Yang X, Castleberry AM, Hall RA. Proteomic analysis of beta1-adrenergic receptor interactions with PDZ scaffold proteins. J Biol Chem 2006;281:2820-2827.
22. Raghuram V, Mak DO, Foskett JK. Regulation of cystic fibrosis transmembrane conductance regulator single-channel gating by bivalent PDZ-domain-mediated interaction. Proc Natl Acad Sci USA 2001;98:1300-1305.
23. Naren AP, Cobb B, Li C, Roy K, Nelson D, Heda GD, Liao J, Kirk KL, Sorscher EJ, Hanrahan J, et al. A macromolecular complex of beta 2 adrenergic receptor, CFTR, and ezrin/radixin/moesin-binding phosphoprotein 50 is regulated by PKA. Proc Natl Acad Sci USA 2003;100:342-346.
24. Bossard F, Robay A, Toumaniantz G, Dahimene S, Becq F, Merot J, Gauthier C. NHE-RF1 protein rescues DeltaF508-CFTR function. Am J Physiol Lung Cell Mol Physiol 2007;292:L1085-L1094.
25. + exchanger regulatory factor isoform 1 overexpression modulates cystic fibrosis transmembrane conductance regulator (CFTR) expression and activity in human airway 16HBE14o2 cells and rescues DeltaF508 CFTR functional expression in cystic fibrosis cells. J Biol Chem 2005;280:40925-40933.
26. Cozens AL, Yezzi MJ, Kunzelmann K, Ohrui T, Chin L, Eng K, Finkbeiner WE, Widdicombe JH, Gruenert DC. CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am J Respir Cell Mol Biol 1994;10:38-47.
27. Thiagarajah JR, Song Y, Haggie PM, Verkman AS. A small molecule CFTR inhibitor produces cystic fibrosis-like submucosal gland fluid secretions in normal airways. FASEB J 2004;18:875-877.
28. Bianchetti A, Manara L. In vitro inhibition of intestinal motility by phenylethanolaminotetralines: evidence of atypical beta-adrenoceptors in rat colon. Br J Pharmacol 1990;100:831-839. (Pubitemid 20233327)
29. He J, Xu J, Castleberry AM, Lau AG, Hall RA. Glycosylation of beta(1)-adrenergic receptors regulates receptor surface xpression and dimerization. Biochem Biophys Res Commun 2002;297: 565-572.
30. Leblais V, Demolombe S, Vallette G, Langin D, Baro I, Escande D, Gauthier C. Beta3-adrenoceptor control the cystic fibrosis transmembrane conductance regulator through a cAMP/protein kinase A-independent pathway. J Biol Chem 1999;274:6107-6113.
31. Taouil K, Hinnrasky J, Hologne C, Corlieu P, Klossek J-M, Puchelle E. Stimulation of beta 2-adrenergic receptor increases cystic fibrosis transmembrane conductance regulator expression in human airway epithelial cells through a cAMP/protein kinase A-independent pathway. J Biol Chem 2003;278:17320-17327.
32. Sharma RK, Jeffery PK. Airway beta-adrenoceptor number in cystic fibrosis and asthma. Clin Sci (Lond) 1990;78:409-417.
33. Mak JC, Chuang TT, Harris CA, Barnes PJ. Increased expression of G protein-coupled receptor kinases in cystic fibrosis lung. Eur J Pharmacol 2002;436:165-172.
34. Mortensen J, Hansen A, Falk M, Nielsen IK, Groth S. Reduced effect of inhaled beta 2-adrenergic agonists on lung mucociliary clearance in patients with cystic fibrosis. Chest 1993;103:805-811.
35. Salpeter SR, Ormiston TM, Salpeter EE. Meta-analysis: respiratory tolerance to regular beta2-agonist use in patients with asthma. Ann Intern Med 2004;140:802-813.
36. Schoni MH, Turler K, Kaser H, Kraemer R. Plasma and urinary catecholamines in patients with cystic fibrosis. Pediatr Res 1985;19: 47-52.
37. Moniotte S, Kobzik L, Feron O, Trochu JN, Gauthier C, Balligand JL. Upregulation of beta(3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium. Circulation 2001;103:1649-1655.
38. Mallem MY, Toumaniantz G, Serpillon S, Gautier F, Gogny M, Desfontis JC, Gauthier C. Impairment of the low-affinity state beta1-adrenoceptor-induced relaxation in spontaneously hypertensive rats. Br J Pharmacol 2004;143:599-605.
39. Portillo MP, Del Barrio AS, Garcia-Calonge MA, Martinez JA. Desensitization effect of in vivo treatment with metaproterenol on beta1, beta2 and beta3-adrenergic responsiveness in rat adipocytes. Life Sci 1996;58:405-414.